益生菌和益生菌治疗性结肠炎的发展:一种疗法已经获得了相当大的势头
Jing Guo1, Liping Li1, Yue Cai2
1Department of microbiology and immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.
Cell communication and signaling : CCS
|May 14, 2024
概括
性结肠炎 (UC) 是一个日益严重的全球健康问题. 本综述探讨了益生菌和益生菌如何通过调节肠道微生物群来为UC提供安全有效的治疗方法.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC) 是一种炎症性肠病 (IBD) 的形式,在全球范围内越来越普遍.
- 结核病带来了巨大的财务负担,并带有发展为癌症的风险.
- 目前的治疗方法,如氨基酸盐和皮质类固醇有局限性,包括副作用和低成功率.
研究的目的:
- 审查最近关于肠道微生物群在UC发展中的作用的文献.
- 评估益生菌和益生菌在UC管理中的治疗潜力.
- 支持益生菌和益生菌在治疗UC的临床应用.
主要方法:
- 对UC,肠道微生物组,益生菌和益生菌现有出版物的文献综述.
- 分析研究的分析,研究益生菌和益生菌影响UC的机制.
- 综合关于这些干预措施的有效性和安全性的证据.
主要成果:
- 肠道微生物群失生症与UC的发病有关.
- 通过益生菌和益生菌调节肠道微生物群,显示出UC治疗的前景.
- 益生菌和益生菌可能为传统疗法提供更安全,更有效的替代方案.
结论:
- 益生菌和益生菌是UC治疗的有价值的治疗策略.
- 需要进一步的研究和临床试验,以优化它们在UC管理中的应用.
- 针对肠道微生物组具有显著的潜力,可以改善UC患者的治疗结果.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
136
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
136
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89


